JACOB PERRIN: Open Payments
NPI 1649860776 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,334 in 60 payments from 24 companies in 2025. Trend: 2023 $567 · 2024 $714 · 2025 $1,334
Food & beverage: $1,142Education: $192
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $196 |
| ABBVIE INC. | 14 | $182 |
| UCB, Inc. | 4 | $114 |
| GENZYME CORPORATION | 4 | $103 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $101 |
| E.R. Squibb & Sons, L.L.C. | 1 | $92 |
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 4 | $67 |
| PFIZER INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ILUMYA, Sotyktu, SKYRIZI, MOUNJARO, RINVOQ.
Industry payments across MI — which companies pay providers there.
